Viking Therapeutics (0VQA)
LSE • 0VQA • US92686J1060
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 8.2% of free float sold short, 456.7 days to cover, cost to borrow 0.49%. Sign up for live short interest data.
Market Cap
3.42b USD | # 1483 in GB
Volume
25.59k shares | 153.13m USD
Shares Outstanding
127.52m
Free Float Shares
97.71% | 124.6m
